BIOMAT Database Logo BIOMAT Database Logo

Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. 1995

B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Glaxo Gastroenterology Research Laboratory, Royal Brisbane Hospital Clinical Research Centre, Bancroft Centre, Australia.

Allelic loss is a common mechanism of inactivation of tumour-suppressor genes in colorectal carcinomas. A number of known or putative tumour-suppressor genes including NF1, BRCA1, NME1, NME2 and prohibitin are present on the long arm of chromosome 17, and this region has not been extensively analysed in colorectal tumours. In this study 72 colorectal carcinomas were examined for allelic loss at eight loci on chromosome 17. Allelic loss was frequent both at the p53 locus, which is known to be important in colorectal carcinoma, and also telomeric to p53 on 17p. Allelic loss continued to be present in more than 50% of cases in the pericentromeric region and on proximal 17q to the marker LEW101 (D17S40) at 17q22-23. The most telomeric markers on 17q showed lower rates of allelic loss. Analysis of cases with partial deletions which did not include the p53 locus showed a common region of overlap of the deletions centred on D17S40. This suggests the target of allelic loss on 17q is a tumour-suppressor gene in this region.

UI MeSH Term Description Entries
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002886 Chromosomes, Human, Pair 17 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 17
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005807 Genes, Overlapping Genes whose nucleotide sequences overlap to some degree. The overlapped sequences may involve structural or regulatory genes of eukaryotic or prokaryotic cells. Overlapping Genes,Gene, Overlapping,Overlapping Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions

Related Publications

B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas.
March 1988, International journal of cancer,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: evidence for three discrete tumor suppressor gene loci.
January 1999, Oncology reports,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
New target region of allelic loss in hepatocellular carcinomas within a 1-cM interval on chromosome 6q23.
July 2000, Journal of hepatology,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Frequent allelic loss/imbalance on the short arm of chromosome 3 in tongue cancer.
August 2001, The Bulletin of Tokyo Dental College,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas.
April 2002, Brain pathology (Zurich, Switzerland),
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas.
August 2003, International journal of cancer,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.
January 1995, Cancer genetics and cytogenetics,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer.
October 1999, Gastroenterology,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.
March 1993, Human genetics,
B Leggett, and J Young, and R Buttenshaw, and L Thomas, and B Young, and G Chenevix-Trench, and J Searle, and M Ward
Frequent allelic loss on chromosome 9 in hepatocellular carcinoma.
May 1999, International journal of cancer,
Copied contents to your clipboard!